Contact information
Peter Scanlon
MD FRCP FRCOphth FHEA DCH DRCOG DO
Associate Professor
- Tutor and Senior Research Fellow, Harris Manchester College
Prof. Peter Scanlon has been Clinical Director for the English NHS Diabetic Eye Screening Programme since 2003, and he has, with the support and co-operation of colleagues, moved screening from limited ad hoc delivery of services to systematic quality assured processes for screening, assessment and treatment across all of England to 2.3 million people with diabetes. Dr Scanlon also holds an appointment as a Senior Research Fellow and Medical Tutor at Harris Manchester College, University of Oxford, and as Visiting Professor at the University of Gloucestershire. Dr Scanlon is Lead Author of the textbook ‘Practical Manual of Diabetic Retinopathy Management’ and has written the Diabetic Retinopathy Chapter for the Textbook of Diabetes, 4th Edition (both Wiley Blackwell).
His research interests lie in the Screening, Epidemiology, Assessment and Treatment of Diabetic Retinopathy and he has published extensively in these areas.
Recent publications
-
Effect of the COVID-19 pandemic on diabetic retinopathy and referral levels in the English National Health Service Diabetic Eye Screening Programme.
Journal article
Scanlon PH. et al, (2025), Diabet Med
-
The Effects of Aspirin and Omega-3 Fatty Acids on Age-Related Macular Degeneration in ASCEND-Eye, A Randomised Placebo Controlled Trial in a Population with Diabetes
Journal article
SAMMONS E., (2025), BMJ Open
-
The Scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 1.
Journal article
Scanlon PH. et al, (2024), Eye (Lond), 38, 3539 - 3546
-
The scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 2.
Journal article
Scanlon PH. et al, (2024), Eye (Lond), 38, 3547 - 3553
-
ASCEND-Eye
Journal article
Sammons EL. et al, (2024), Ophthalmology, 131, 771 - 779